Company Overview and News
Tech stocks have served as the backbone of market growth in many respects. Not only has the tech industry boomed but technology has fundamentally reshaped other industries such as retail, media and transportation. But many companies at the center of this tech boom may have run too high too fast, leading to very high(P/E) ratios. And investors should be checking their portfolios for overvalued tech stocks.
INTU SQ AMZN NOW AAPL CSCO PYPL NFLX INTC DIS WMT
5h zacks - 1
FANGs are Wall Street’s hot sellers. But overvaluation concerns are rife for FANGs.Bank of America Merrill Lynch analysts, raised warnings ahead of FANG investing and asked investors to sell the sector “on signs inflows have reached bubble territory.”
VGT GOOGL RTH NFLX WMT
Streaming giant Netflix (NASDAQ:NFLX) entered 2018 as the poster child for big-growth tech stocks. Netflix stock maintained that standing for a good part of the year, and at one point in early July, Netflix was up 120% year-to-date.
Don’t misread the message. Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) still effectively “owns” the internet, with its Google arm facilitating 86% of the world’s web searches. And, GOOGL stock has been one of the market’s most reliable winners for investors willing to stick with it for the long haul.
FOX CMCSA TWX NFLX GOOG TWC AMZN T GOOGL ROKU AAPL FOXA DIS
For several years between early 2015 and mid 2018, shares of entertainment giant Disney (NYSE:DIS) were stuck in neutral. The company was plagued by cord-cutting headwinds which depressed its biggest operating segment (Media Networks). That caused earnings growth and Disney stock to fall flat.
Back in March I began talking about the strength in consumer stocks, particularly brick-and-mortar names. Of course, most financial analysts had written off the brick and mortars as victims of the Amazon (NASDAQ:AMZN) era and the lingering impact on consumer behavior in the aftermath of the Great Recession.
DDS JWN AMZN M NFLX
Netflix (NFLX) is not only priced to perfection, it actually makes for a very risky investment. While Netflix had very successfully disrupted the bigger players, I contend that present shareholders are vastly overpaying to participate in its opportunity.
GOOGL NFLX GOOG DIS
Netflix (NASDAQ: NFLX) has certainly had a tough time of it recently. After being one of the best performing internet stocks in the first half of the year, NFLX stock has crashed back to reality. Shares dropped more than 20% from the recent all-time highs following earnings on July 16th. Certainly some of the sell off was warranted given the disappointing subscriber growth and ongoing cash burn. But the magnitude of the selling has now gone too far.
U.S. stock futures are trending higher this morning. Wall Street is shifting its focus from corporate earnings to the Federal Reserve this week. The central bank will offer up minutes from its latest meeting this Wednesday, while Fed Chairman Jerome Powell will give a speech in Jackson Hole at the Fed’s annual summer retreat.
FLEX BABA NFLX
HP (NYSE:HPQ) is flying high heading into this week’s earnings report. Poor reports from FAANG tech stocks like Facebook (NASDAQ:FB) and Netflix (NASDAQ:NFLX) left a bad taste in investors mouths this earnings season. But the fall in FAANGs has been a boon for value plays in the tech sector. And HPQ stock is benefitting.
FB NFLX HPQ
Intending to get a jumpstart in the digital revolution, IMAX (IMAX - Free Report) had ventured into the virtual reality (VR) space. However, it seems to have failed in achieving the desired results. Reportedly, the company plans to halt the pilot program, which started in early 2017. In this connection, the company has closed two of its VR centers and will shortly decide the fate of the remaining centers.
GOOGL NFLX IMAX
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...
as of ET